HomeNRXPW • NASDAQ
add
NRX Pharmaceuticals Inc
Previous close
$0.15
Year range
$0.040 - $0.50
Market cap
74.64M USD
Avg Volume
13.70K
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.73M | -47.09% |
Net income | -17.58M | -122.63% |
Net profit margin | — | — |
Earnings per share | -0.98 | -30.67% |
EBITDA | -3.73M | 47.10% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.91M | 53.32% |
Total assets | 4.84M | -8.09% |
Total liabilities | 40.45M | 71.01% |
Total equity | -35.62M | — |
Shares outstanding | 19.71M | — |
Price to book | -0.08 | — |
Return on assets | -150.06% | — |
Return on capital | 43.86% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -17.58M | -122.63% |
Cash from operations | -4.03M | -57.22% |
Cash from investing | — | — |
Cash from financing | 1.39M | -55.75% |
Net change in cash | -2.64M | -555.61% |
Free cash flow | 4.01M | 400.00% |
About
Founded
2015
Headquarters
Website
Employees
2
